Narikazu Boku
Papers
1
Total Citations
33
H-Index
1
About
Dr. Narikazu Boku is a leading figure in surgical oncology, with a primary focus on advancing the treatment of gastric cancer through minimally invasive techniques. His major contribution lies in the rigorous, large-scale clinical evaluation of robotic surgery. As the principal investigator of the landmark MONA LISA study (JCOG1907), he is spearheading the first randomized controlled phase III trial to determine if robot-assisted gastrectomy is superior to the current standard, laparoscopic gastrectomy, for patients with clinical stage T1-4aN0-3 gastric cancer. This work, published in 2023 and already garnering 33 citations, addresses critical drawbacks of conventional laparoscopy, such as motion restriction and spatial perception difficulties, by leveraging the articulated instruments of robotic systems. Dr. Boku’s research is pivotal in defining the future role of robotic platforms in oncologic surgery, with the potential to set a new global standard for gastric cancer care. His leadership in this high-impact trial underscores his commitment to evidence-based surgical innovation.
Research Focus
Key Achievements
Top Papers
- 1